ロード中...
Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges
In oncology, an increasing number of targeted anticancer agents and immunotherapies are of biological origin. These biological drugs may trigger immune responses that lead to the formation of antidrug antibodies (ADAs). ADAs are directed against immunogenic parts of the drug and may affect efficacy...
保存先:
| 出版年: | Oncologist |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AlphaMed Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5061540/ https://ncbi.nlm.nih.gov/pubmed/27440064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0061 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|